I‐Lu Lai
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Pharmacology top 5%
- Berberine and alkaloids research
Papers in
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 2
- Natural product bioactivities and synthesis 2
- Epigenetics and DNA Methylation 2
-
- Cancer-related molecular mechanisms research 5
- Co-authors
- Kuen‐Haur Lee (3 shared papers)Ching‐Shih Chen (3 shared papers)Xiaokui Mo (2 shared papers)Chin‐An Yang (4 shared papers)Samuel K. Kulp (2 shared papers)Jan‐Gowth Chang (6 shared papers)Wen‐Ming Yang (5 shared papers)Yali Yao (4 shared papers)
- Journals
- International Journal of Molecular Sciences (3 papers)Journal of Biological Chemistry (2 papers)Biochemical and Biophysical Research Communications (1 paper)The Prostate (1 paper)Gene (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
I‐Lu Lai
21 papers receiving 767 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 238
- Pharmacology 75
- Molecular Biology 523
- Pharmacology 82
- Oncology 121
Countries citing papers authored by I‐Lu Lai
This map shows the geographic impact of I‐Lu Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Lu Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Lu Lai more than expected).
Fields of papers citing papers by I‐Lu Lai
This network shows the impact of papers produced by I‐Lu Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Lu Lai. The network helps show where I‐Lu Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside I‐Lu Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 146 | |
| 2 | 2015 | 79 | |
| 3 | 2014 | 72 | |
| 4 | 2018 | 58 | |
| 5 | 2015 | 52 | |
| 6 | 2017 | 46 | |
| 7 | 2001 | 43 | |
| 8 | 2016 | 41 | |
| 9 | 2009 | 37 | |
| 10 | 2002 | 35 | |
| 11 | 2013 | 31 | |
| 12 | 2019 | 31 | |
| 13 | 2015 | 27 | |
| 14 | 2006 | 26 | |
| 15 | 2006 | 17 | |
| 16 | 2012 | 16 | |
| 17 | 2003 | 11 | |
| 18 | 2023 | 6 | |
| 19 | 2022 | 3 | |
| 20 | 2023 | 1 |
About I‐Lu Lai
I‐Lu Lai is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Oncology and Pharmacology, having authored 21 papers that have together received 779 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers), Liver Disease Diagnosis and Treatment (2 papers), Circular RNAs in diseases (2 papers), Hepatitis C virus research (2 papers), Natural product bioactivities and synthesis (2 papers), Epigenetics and DNA Methylation (2 papers) and Berberine and alkaloids research (2 papers). The work is most often cited by research in Cancer Research (238 citations), Pharmacology (75 citations), Molecular Biology (523 citations), Pharmacology (82 citations) and Oncology (121 citations). I‐Lu Lai has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Kuen‐Haur Lee, Ching‐Shih Chen, Xiaokui Mo, Chin‐An Yang, Samuel K. Kulp, Jan‐Gowth Chang, Wen‐Ming Yang, Yali Yao, Tin‐Yun Ho and Chien‐Yun Hsiang. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Biological Chemistry, Biochemical and Biophysical Research Communications, The Prostate and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.